Gain Therapeutics is a preclinical stage biotech company developing next-generation brain-penetrant non-competitive small molecules for the treatment of devastating lysosomal storage diseases and CNS indications using the proprietary SEE-Tx® technology.

Cooperation possibilities

The company has several discovery programs that offer significant partnering opportunities. The proprietary SEE-Tx® technology can also provide partnering opportunities for the discovery of novel brain-penetrant small molecules against selected targets.


Via Francesco Soave 6, 6900 Lugano, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland